Viewing Study NCT02507232


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-01-04 @ 5:28 PM
Study NCT ID: NCT02507232
Status: TERMINATED
Last Update Posted: 2020-07-28
First Post: 2015-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Sponsor: Santosh Kesari
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module